BAYER20511: Open-label, Non-randomized Phase 1, Multicenter Study to Assess Radium- 223 Biodistribution in Participants With Bone Metastatic Castration Resistant Prostate Cancer (CRPC) Receiving Radium-223 Dichloride Treatment
Principal investigator: Katriina Peltola
Trial site: HUS Comprehensive Cancer Center